Validated HPLC method for the determination of gabapentin in human plasma using pre-column derivatization with 1-fluoro-2,4-dinitrobenzene and its application to a pharmacokinetic study

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):43-7. doi: 10.1016/j.jchromb.2007.03.039. Epub 2007 Apr 5.

Abstract

A rapid, sensitive and accurate high-performance liquid chromatographic method with UV detection was developed and validated for the quantification of gabapentin in human plasma. Gabapentin was quantified using pre-column derivatization with 1-fluoro-2,4-dinitrobenzene following protein precipitation of plasma with acetonitrile. Amlodipine was used as internal standard. The chromatographic separation was carried out on a Nova-Pak C(18) column using a mixture of 50 mM NaH(2)PO(4) (pH=2.5)-acetonitrile (30:70, v/v) as mobile phase with UV detection at 360 nm. The flow rate was set at 1.5 ml/min. The method was linear over the range of 0.05-5 microg/ml of gabapentin in plasma (r(2)>0.999). The within-day and between-day precision values were in the range of 2-5%. The limit of quantification of the method was 0.05 microg/ml. The method was successfully used to study the pharmacokinetics of gabapentin in healthy volunteers.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Amines / blood*
  • Amines / pharmacokinetics
  • Calibration
  • Chromatography, High Pressure Liquid / methods*
  • Cyclohexanecarboxylic Acids / blood*
  • Cyclohexanecarboxylic Acids / pharmacokinetics
  • Dinitrofluorobenzene / chemistry*
  • Gabapentin
  • Humans
  • Male
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet
  • gamma-Aminobutyric Acid / blood*
  • gamma-Aminobutyric Acid / pharmacokinetics

Substances

  • Amines
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Dinitrofluorobenzene